4.11 - Pharmacogenomics Flashcards
Define pharmacogenomics
Study of the impact of genetic polymorphisms on drug response
- To personalize/individualize drug therapy
What does pharmacogenomics promise?
The possibility that knowledge of a patient’s DNA sequence could be used to enhance pharmacotherapy
___ are the most common gene variations associated w/ drug response
SNPs
Where can gene modifications occur?
- In the gene
- In the promoters
- Enhancers
- Splice sites
- Sites that control gene transcription or mRNA stability
What types of variations are associated with pharmacokinetics?
- Variation in enzymes of drug metabolism
- Variation in transporters
What genetic variations are associated w/ pharmacodynamics?
Variation in drug targets
Pharmacodynamic and pharmacokinetic interactions have a ___ effect
Polygenic
Genetic variation in ___ affects HLA polymorphism
Immune system function
What are phase 1 and 2 of pharmacokinetics?
- Phase 1 = oxidation/reduction enzymes
- Phase 2 = conjugation enzymes
CYP2D6 converts codeine to
Morphine
In CYP2D6, ___ function is associated with increased toxicity
Increased
IN CYP2D6, decreased function is associated w/ ___
Decreased analgesia
Reduced function in thiopurine S-methyltransferase (TPMT) is associated w/
Increased thiopurine (azathioprine, 6-mercaptopurine, 6-thioguanine) toxicity
In CYP2D6, ultra-rapid metabolizer phenotype has what dosing recommendation?
- Alternative analgesic
- Increased formation of morphine following codeine admin leads to higher risk of toxicity
In CYP2D6, ___ metabolizer phenotype has a standard dosing rate
Extensive metabolizer phenotype